15
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          Gonadotropin-releasing hormone agonist (GnRHa) could influence the levels of sex hormones and thyroid hormones. The aim of this study was to investigate the effect of GnRHa on thyroid function.

          Materials and methods

          The data of the patients were collected from the registrations of July 2014–October 2014. A total of 41 women who underwent one-time IVF cyclus were evaluated in this cross-sectional study. The patients were categorized into two groups according to the serum T 3, T 4, and TSH levels before and 2 weeks’ after the administration of GnRHa.

          Results

          Mean basal TSH and mean TSH levels on hCG day were 1.98 ± 0.77 and 1.75 ± 0.70, respectively. The difference between the two groups was statistically significant ( p < 0.05). GnRHa did not lead to statistically significant difference on serum-free T 3 and T 4 levels.

          Conclusions

          In conclusion, our results demonstrate that GnRHa led to a decrease on serum TSH level. Serum-free T 3 and T 4 levels were remained unchanged and this might be due to early measurement of the hormone levels (just 2 weeks later from GnRHa administration).

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.

          Human reproduction depends on an intact hypothalamic-pituitary-gonadal (HPG) axis. Hypothalamic gonadotrophin-releasing hormone (GnRH) has been recognized, since its identification in 1971, as the central regulator of the production and release of the pituitary gonadotrophins that, in turn, regulate the gonadal functions and the production of sex steroids. The characteristic peculiar development, distribution and episodic activity of GnRH-producing neurons have solicited an interdisciplinary interest on the etiopathogenesis of several reproductive diseases. The more recent identification of a GnRH/GnRH receptor (GnRHR) system in both the human endometrium and ovary has widened the spectrum of action of the peptide and of its analogues beyond its hypothalamic function.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Gonadotropin-releasing hormone and its analogues.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist

              Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones. Recently, we found that the long-acting GnRH agonist aggravated hyperthyroidism and induced painless thyroiditis. This is the first report to demonstrate the association of thyroid dysfunction with GnRH agonist injection in Korea. Here, we report three cases and emphasize the clinical importance of this aggravating factor in autoimmune thyroid disease.
                Bookmark

                Author and article information

                Journal
                imas
                1646
                Interventional Medicine and Applied Science
                IMAS
                Akadémiai Kiadó (Budapest )
                2061-1617
                2061-5094
                16 September 2020
                11 November 2019
                : 11
                : 3
                : 136-138
                Affiliations
                [ 1 ]Department of Obstetrics and Gynecology, Zekai Tahir Burak Women’s Health Education and Research Hospital , Ankara, Turkey
                [ 2 ]Department of Obstetrics and Gynecology, School of Medicine, Bozok University , Yozgat, Turkey
                Author notes
                [* ]Corresponding author: Mustafa Kara; Department of Obstetrics and Gynecology, School of Medicine, Bozok University, Adnan Menderes Boulevard No. 44, 66200 Yozgat, Turkey; Phone: +90 354 212 70 01; Fax: +90 354 212 27 89; GSM: +90 533 622 65 01; E-mails: mustafa.kara@ 123456bozok.edu.tr ; m.kara66@ 123456hotmail.com
                Article
                10.1556/1646.10.2018.32
                6f3e5e28-f733-4606-8a6b-c1614b7d9270
                © 2019 The Author(s)

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.

                History
                : 11 April 2018
                : 10 May 2018
                : 22 May 2018
                Page count
                Figures: 0, Tables: 2, Equations: 0, References: 11, Pages: 3
                Funding
                Funding sources: None.

                Medicine,Immunology,Health & Social care,Microbiology & Virology,Infectious disease & Microbiology
                infertility,GnRHa,gonadotropin,thyroid hormones,IVF–ICSI

                Comments

                Comment on this article